Table 1.

Demographic and clinical characteristics of the enrolled mCRC patients.

Patient Characteristics	n (%)
Gender
Male	20 (67%)
Female	10 (33%)
Age in years
Mean	68
Range	43–83
Primary tumor location
Right colon	16 (53%)
Left colon/Rectum	14 (47%)
First line chemotherapy
Oxaliplatin-based doublet	21 (70%)
Irinotecan-based doublet	4 (13%)
Other 1	5 (17%)
First line targeted agent
Anti-angiogenic	15 (50%)
Anti-EGFR	11 (37%)
None	4 (13%)
Total	30 (100%)

¹ Triplet, single agent or other.